What We Do

 

SFC Fluidics seeks to become a leader in the $9B insulin delivery market by bringing healthcare closer to patients with diabetes. Using proprietary micro-fluidics, the Company is developing a connected, wearable drug dosing system that automates insulin delivery, which in turn allows patients with diabetes to live an active lifestyle while avoiding serious complications such as blindness, amputation, and heart disease.